Selected research
Industry Research
Biodegradable Medical Polymer Industry Research Report 2026
Market perspective
The global Biodegradable Medical Polymer market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Biodegradable Medical Polymer is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Biodegradable Medical Polymer is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Biodegradable Medical Polymer is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Biodegradable Medical Polymer include Poly-Med, PCAS, Mitsui Chemicals, KLS Martin, Evonik, DSM and Corbion, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Biodegradable Medical Polymer market in terms of revenue (US$ million) and, where applicable, sales volume (k tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Biodegradable Medical Polymer Market by Company
Poly-Med
PCAS
Mitsui Chemicals
KLS Martin
Evonik
DSM
Corbion
Biodegradable Medical Polymer Segment by Type
Polysaccharides
Polycaprolactone (PCL)
Polylactic Acid (PLA)
PLGA
Polyglycolic Acid (PGA)
Biodegradable Medical Polymer Segment by Application
Drug Delivery
Orthopedics
Others
Biodegradable Medical Polymer Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biodegradable Medical Polymer market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biodegradable Medical Polymer and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biodegradable Medical Polymer.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Biodegradable Medical Polymer manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Biodegradable Medical Polymer by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Biodegradable Medical Polymer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Polysaccharides
- Polycaprolactone (PCL)
- Polylactic Acid (PLA)
- PLGA
- Polyglycolic Acid (PGA)
Applications
- Drug Delivery
- Orthopedics
- Others
Companies covered
- Poly-Med
- PCAS
- Mitsui Chemicals
- KLS Martin
- Evonik
- DSM
- Corbion
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Biodegradable Medical Polymer Market Size (2021-2032)
- 2.2.2 Global Biodegradable Medical Polymer Sales (2021-2032)
- 2.2.3 Global Biodegradable Medical Polymer Market Average Price (2021-2032)
- 2.3 Biodegradable Medical Polymer by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Polysaccharides
- 2.3.3 Polycaprolactone (PCL)
- 2.3.4 Polylactic Acid (PLA)
- 2.3.5 PLGA
- 2.3.6 Polyglycolic Acid (PGA)
- 2.4 Biodegradable Medical Polymer by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Drug Delivery
- 2.4.3 Orthopedics
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Biodegradable Medical Polymer Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Biodegradable Medical Polymer Sales (k tons) of Manufacturers (2021-2026)
- 3.3 Global Biodegradable Medical Polymer Revenue of Manufacturers (2021-2026)
- 3.4 Global Biodegradable Medical Polymer Average Price by Manufacturers (2021-2026)
- 3.5 Global Biodegradable Medical Polymer Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Biodegradable Medical Polymer, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Biodegradable Medical Polymer, Product Type & Application
- 3.8 Global Manufacturers of Biodegradable Medical Polymer, Established Date
- 3.9 Global Biodegradable Medical Polymer Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Poly-Med
- 4.1.1 Poly-Med Company Information
- 4.1.2 Poly-Med Business Overview
- 4.1.3 Poly-Med Biodegradable Medical Polymer Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Poly-Med Biodegradable Medical Polymer Product Portfolio
- 4.1.5 Poly-Med Recent Developments
- 4.2 PCAS
- 4.2.1 PCAS Company Information
- 4.2.2 PCAS Business Overview
- 4.2.3 PCAS Biodegradable Medical Polymer Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 PCAS Biodegradable Medical Polymer Product Portfolio
- 4.2.5 PCAS Recent Developments
- 4.3 Mitsui Chemicals
- 4.3.1 Mitsui Chemicals Company Information
- 4.3.2 Mitsui Chemicals Business Overview
- 4.3.3 Mitsui Chemicals Biodegradable Medical Polymer Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Mitsui Chemicals Biodegradable Medical Polymer Product Portfolio
- 4.3.5 Mitsui Chemicals Recent Developments
- 4.4 KLS Martin
- 4.4.1 KLS Martin Company Information
- 4.4.2 KLS Martin Business Overview
- 4.4.3 KLS Martin Biodegradable Medical Polymer Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 KLS Martin Biodegradable Medical Polymer Product Portfolio
- 4.4.5 KLS Martin Recent Developments
- 4.5 Evonik
- 4.5.1 Evonik Company Information
- 4.5.2 Evonik Business Overview
- 4.5.3 Evonik Biodegradable Medical Polymer Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Evonik Biodegradable Medical Polymer Product Portfolio
- 4.5.5 Evonik Recent Developments
- 4.6 DSM
- 4.6.1 DSM Company Information
- 4.6.2 DSM Business Overview
- 4.6.3 DSM Biodegradable Medical Polymer Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 DSM Biodegradable Medical Polymer Product Portfolio
- 4.6.5 DSM Recent Developments
- 4.7 Corbion
- 4.7.1 Corbion Company Information
- 4.7.2 Corbion Business Overview
- 4.7.3 Corbion Biodegradable Medical Polymer Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Corbion Biodegradable Medical Polymer Product Portfolio
- 4.7.5 Corbion Recent Developments
5 Global Biodegradable Medical Polymer Market Scenario by Region
- 5.1 Global Biodegradable Medical Polymer Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Biodegradable Medical Polymer Sales by Region: 2021-2032
- 5.2.1 Global Biodegradable Medical Polymer Sales by Region: 2021-2026
- 5.2.2 Global Biodegradable Medical Polymer Sales by Region: 2027-2032
- 5.3 Global Biodegradable Medical Polymer Revenue by Region: 2021-2032
- 5.3.1 Global Biodegradable Medical Polymer Revenue by Region: 2021-2026
- 5.3.2 Global Biodegradable Medical Polymer Revenue by Region: 2027-2032
- 5.4 North America Biodegradable Medical Polymer Market Facts & Figures by Country
- 5.4.1 North America Biodegradable Medical Polymer Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Biodegradable Medical Polymer Sales by Country (2021-2032)
- 5.4.3 North America Biodegradable Medical Polymer Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Biodegradable Medical Polymer Market Facts & Figures by Country
- 5.5.1 Europe Biodegradable Medical Polymer Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Biodegradable Medical Polymer Sales by Country (2021-2032)
- 5.5.3 Europe Biodegradable Medical Polymer Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Biodegradable Medical Polymer Market Facts & Figures by Country
- 5.6.1 Asia Pacific Biodegradable Medical Polymer Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Biodegradable Medical Polymer Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Biodegradable Medical Polymer Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Biodegradable Medical Polymer Market Facts & Figures by Country
- 5.7.1 South America Biodegradable Medical Polymer Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Biodegradable Medical Polymer Sales by Country (2021-2032)
- 5.7.3 South America Biodegradable Medical Polymer Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Biodegradable Medical Polymer Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Biodegradable Medical Polymer Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Biodegradable Medical Polymer Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Biodegradable Medical Polymer Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Biodegradable Medical Polymer Sales by Type (2021-2032)
- 6.1.1 Global Biodegradable Medical Polymer Sales by Type (2021-2032) & (k tons)
- 6.1.2 Global Biodegradable Medical Polymer Sales Market Share by Type (2021-2032)
- 6.2 Global Biodegradable Medical Polymer Revenue by Type (2021-2032)
- 6.2.1 Global Biodegradable Medical Polymer Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Biodegradable Medical Polymer Revenue Market Share by Type (2021-2032)
- 6.3 Global Biodegradable Medical Polymer Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Biodegradable Medical Polymer Sales by Application (2021-2032)
- 7.1.1 Global Biodegradable Medical Polymer Sales by Application (2021-2032) & (k tons)
- 7.1.2 Global Biodegradable Medical Polymer Sales Market Share by Application (2021-2032)
- 7.2 Global Biodegradable Medical Polymer Revenue by Application (2021-2032)
- 7.2.1 Global Biodegradable Medical Polymer Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Biodegradable Medical Polymer Revenue Market Share by Application (2021-2032)
- 7.3 Global Biodegradable Medical Polymer Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Biodegradable Medical Polymer Value Chain Analysis
- 8.1.1 Biodegradable Medical Polymer Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Biodegradable Medical Polymer Production Mode & Process
- 8.2 Biodegradable Medical Polymer Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Biodegradable Medical Polymer Distributors
- 8.2.3 Biodegradable Medical Polymer Customers
9 Global Biodegradable Medical Polymer Analyzing Market Dynamics
- 9.1 Biodegradable Medical Polymer Industry Trends
- 9.2 Biodegradable Medical Polymer Industry Drivers
- 9.3 Biodegradable Medical Polymer Industry Opportunities and Challenges
- 9.4 Biodegradable Medical Polymer Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst